There is still risk with PBT - mainly driven by the fact that we haven't moved to a PIII trial as yet. We are talking about it, but until it happens, some will consider us a risk.
I was quietly thinking that leading up to AD results that the share price would build to the $1.50-$2 range prior to results being announced.
At this stage however, I'm in no hurry to sell my shares. It was an amazing thing after the results of HD were released where about 5% of me cared what the shareprice was going to do on the back of the results, the other 95% of me was stoked for sufferers. The longer time goes on, the less I am concerned about the shareprice.
Shareprice wealth will come to those that are happy to wait.
PBT Price at posting:
94.0¢ Sentiment: LT Buy Disclosure: Held
